777 Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ and hematopoietic cell transplant recipients with advanced cutaneous malignancies (ARTACUS)

Abstract

BackgroundSkin cancers are common post-transplant malignancies in stem cell transplant (SCT) and solid organ transplant (SOT) recipients. The use of immune checkpoint inhibitors has improved outcomes in the general patient...